Clinical Use of Deslorelin for the Control of Reproduction in the Bitch

• Published in: Reproduction in domestic animals 2009-07, Vol.44 (s2), p.36-39
• Main Authors: Romagnoli, S, Stelletta, C, Milani, C, Gelli, D, Falomo, ME, Mollo, A
• Format: Article
• Language: English
• Subjects: Animal reproduction; Animals; Dogs; Dose-Response Relationship, Drug; Drug Implants; Enzyme Inhibitors - administration & dosage; Enzyme Inhibitors - pharmacology; Estrous Cycle - drug effects; Female; Females; Pharmacology; Triptorelin Pamoate - administration & dosage; Triptorelin Pamoate - analogs & derivatives; Triptorelin Pamoate - pharmacology; Veterinary medicine
• ISSN: 0936-6768; 1439-0531
• DOI: 10.1111/j.1439-0531.2009.01441.x

This study was conducted to evaluate clinical efficacy of deslorelin for inhibiting reproduction in the bitch. Ten adult healthy bitches or bitches with mammary neoplasia for which owners were requesting suppression of cyclicity without performing gonadectomy were administered a 4.7- or a 9.4-mg deslorelin implant subcutaneously. The first implant of deslorelin was administered in anoestrus (n = 5) or in dioestrus (n = 5). Treatment was repeated every 5 months for as long as necessary based on the clinical situation of the dog and owner's desires. Some of the bitches implanted in anoestrus came in heat within 4-15 days after treatment, while none of the bitches implanted in dioestrus showed heat during treatment. Suppression of reproductive cyclicity was successfully achieved in 6/10 bitches for 1-4 years. No behavioural and local/general side-effects were observed in any of the treated bitches. The 4.7-mg deslorelin implant may work well for suppression of cyclicity provided that it is administered in dioestrus and at intervals of 4.5 months. A 9.4-mg implant may be more suitable for this use although its efficacy may also be shorter than 12 months. Owner compliance is an important limiting factor.